HomeLIXTW • NASDAQ
add
Lixte Biotechnology
Previous close
$0.022
Year range
$0.010 - $0.38
Market cap
24.54M USD
Avg Volume
37.03K
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.80M | 83.20% |
Net income | -1.98M | -100.85% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.89M | 76.35% |
Total assets | 5.43M | 220.40% |
Total liabilities | 521.42K | 58.51% |
Total equity | 4.91M | — |
Shares outstanding | 5.70M | — |
Price to book | 0.05 | — |
Return on assets | -136.01% | — |
Return on capital | -161.88% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.98M | -100.85% |
Cash from operations | -926.75K | 3.22% |
Cash from investing | -2.64M | — |
Cash from financing | 5.56M | — |
Net change in cash | 2.00M | 308.93% |
Free cash flow | -2.81M | -384.36% |
About
Founded
2005
Headquarters
Website
Employees
2
